RE: Half year results out next week26 Sep 2023 07:06
Those are my questions :
Question 1:
Since mid 2021, you have been busy restructuring the Novacyt Group. this also includes changes in your R&D (abandonment of aspergillus multiplex, abandonment of IVD-R, etc.).
you are now finished, but you are starting a new restructuring, this time between the group and yourgene which you have just acquired.
Are we once again at risk of seeing delays and changes in strategy?
Question 2:
What Can you tell us about the development of the biosensor ?
When will we have a précise R&D update like the one we had back in 2020/2021 ?
Question 3:
The New BoD membres coming from yourgene, havent been able to procure value for shareholders when i see the evolution of their Share Price. Why are they the right people in your opinion to create some to us, novacyt shareholders ?
Question 4:
How are the New distributors doing ? We see several trainings, advertising etc, but how is it going in regards to results ? Do you expect them to increase your sells in the near future ?
Question 5:
You havent bothered yourself updating your website. Still no clonits assays to see anywhere, but also no update for the CTDA approval of your self test COVID LFT.
How Can you explain this, and how long until you have a proper eShop website (shop.novacyt.com) ?
Question 6:
I'm happy to see that youve bought Yourgene. Though, are there still more M&A on tracks ?